Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Lymphoma, T-Cell, Cutaneous × Lenalidomide × 30 days × Clear all

Sponsor

Conditions

Multiple Myeloma 39 Lymphoma, Follicular 12 Lymphoma, Large B-Cell, Diffuse 9 Recurrence 5 Lymphoma, Non-Hodgkin 5 Lymphoma, B-Cell, Marginal Zone 5 Lymphoma 5 Neoplasms 4 Lymphoma, Mantle-Cell 4 Leukemia, Lymphocytic, Chronic, B-Cell 4 Neoplasms, Plasma Cell 3 Smoldering Multiple Myeloma 2 Myelodysplastic Syndromes 2 Lymphoma, B-Cell 2 Leukemia, Myelomonocytic, Chronic 2 Hodgkin Disease 2 Waldenstrom Macroglobulinemia 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Paraproteinemias 1 Neuroblastoma 1 Neoplasm, Residual 1 Lymphoproliferative Disorders 1 Lymphoma, Large-Cell, Immunoblastic 1 Leukemia, Hairy Cell 1 Intraocular Lymphoma 1 Immunoproliferative Disorders 1 HTLV-I Infections 1 GATA2 Deficiency 1 Burkitt Lymphoma 1 Anemia, Refractory, with Excess of Blasts 1

Interventions

Specimen Handling 2 Cyclophosphamide 2 Biopsy 2 tazemetostat 1 talimogene laherparepvec 1 fludarabine phosphate 1 fludarabine 1 belinostat 1 Pharmacogenomic Variants 1 Nivolumab 1 Mycophenolic Acid 1 Mesna 1 Melphalan 1 Magnetic Resonance Spectroscopy 1 MEDI-570 1 Filgrastim 1 Bone Marrow Transplantation 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡